[go: up one dir, main page]

MX2024008143A - Injertos de tejido amniotico y metodos para preparar y usar los mismos. - Google Patents

Injertos de tejido amniotico y metodos para preparar y usar los mismos.

Info

Publication number
MX2024008143A
MX2024008143A MX2024008143A MX2024008143A MX2024008143A MX 2024008143 A MX2024008143 A MX 2024008143A MX 2024008143 A MX2024008143 A MX 2024008143A MX 2024008143 A MX2024008143 A MX 2024008143A MX 2024008143 A MX2024008143 A MX 2024008143A
Authority
MX
Mexico
Prior art keywords
preparing
methods
same
tissue grafts
amnion tissue
Prior art date
Application number
MX2024008143A
Other languages
English (en)
Inventor
Curt Deister
Original Assignee
Axogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axogen Corp filed Critical Axogen Corp
Publication of MX2024008143A publication Critical patent/MX2024008143A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3895—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/22—Materials or treatment for tissue regeneration for reconstruction of hollow organs, e.g. bladder, esophagus, urether, uterus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pens And Brushes (AREA)

Abstract

La invención proporciona un método para preparar injertos de tejido amniótico, así como los injertos en sí mismos. En modalidades específicas, el injerto de tejido comprende una capa sencilla de amnios secado, de un cordón umbilical.
MX2024008143A 2016-11-02 2019-05-02 Injertos de tejido amniotico y metodos para preparar y usar los mismos. MX2024008143A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662416528P 2016-11-02 2016-11-02

Publications (1)

Publication Number Publication Date
MX2024008143A true MX2024008143A (es) 2024-07-15

Family

ID=62076479

Family Applications (3)

Application Number Title Priority Date Filing Date
MX2019005172A MX2019005172A (es) 2016-11-02 2017-11-02 Injertos de tejido amniotico y metodos para preparar y usar los mismos.
MX2024008143A MX2024008143A (es) 2016-11-02 2019-05-02 Injertos de tejido amniotico y metodos para preparar y usar los mismos.
MX2023007919A MX2023007919A (es) 2016-11-02 2019-05-02 Injertos de tejido amniotico y metodos para preparar y usar los mismos.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2019005172A MX2019005172A (es) 2016-11-02 2017-11-02 Injertos de tejido amniotico y metodos para preparar y usar los mismos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2023007919A MX2023007919A (es) 2016-11-02 2019-05-02 Injertos de tejido amniotico y metodos para preparar y usar los mismos.

Country Status (12)

Country Link
US (2) US11577001B2 (es)
EP (2) EP3534981B1 (es)
JP (2) JP7171588B2 (es)
KR (3) KR20230031381A (es)
AU (2) AU2017353847B2 (es)
CA (1) CA3042751A1 (es)
CL (1) CL2019001212A1 (es)
IL (2) IL301474B2 (es)
MX (3) MX2019005172A (es)
NZ (1) NZ753034A (es)
SG (1) SG11201903899VA (es)
WO (1) WO2018085527A2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ753034A (en) * 2016-11-02 2023-04-28 Axogen Corp Amnion tissue grafts and methods of preparing and using same
WO2023021525A1 (en) * 2021-08-16 2023-02-23 Lifecell International Pvt. Ltd A human amnion-chorion based wound dressing material and method thereof

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801299A (en) * 1983-06-10 1989-01-31 University Patents, Inc. Body implants of extracellular matrix and means and methods of making and using such implants
DE69416124T2 (de) 1993-06-18 1999-08-05 Polymer Technology Corp Zusammensetzung zur reinigung und befeuchtung von kontaktlinsen
US20030187515A1 (en) 2002-03-26 2003-10-02 Hariri Robert J. Collagen biofabric and methods of preparing and using the collagen biofabric
US8100872B2 (en) * 2002-10-23 2012-01-24 Tyco Healthcare Group Lp Medical dressing containing antimicrobial agent
WO2005001080A2 (en) * 2003-06-27 2005-01-06 Ethicon, Incorporated Postpartum-derived cells for use in treatment of disease of the heart and circulatory system
ES2537030T3 (es) * 2004-03-17 2015-06-01 Revivicor, Inc. Productos de tejidos derivados de animales que carecen de cualquier expresión de alfa-1,3-galactosiltransferasa funcional
EP1919500A2 (en) * 2005-07-13 2008-05-14 Anthrogenesis Corporation Treatment of leg ulcers using placenta derived collagen biofabric
EP1944045B1 (en) * 2005-07-25 2013-09-18 Foundation for Biomedical Research and Innovation Sheet-like composition
US8932641B2 (en) 2005-08-26 2015-01-13 Amnos Co., Ltd. Dried amnion and method for drying treatment of amnion
WO2007029676A1 (ja) * 2005-09-07 2007-03-15 Arblast Co., Ltd. 生体組織シート及びその作製方法
US8187639B2 (en) * 2005-09-27 2012-05-29 Tissue Tech, Inc. Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
CN2905071Y (zh) * 2006-04-07 2007-05-30 苗九昌 生物羊膜
JP2008022715A (ja) 2006-07-18 2008-02-07 Nipro Corp 細胞シート培養方法及び細胞培養容器
WO2008021391A1 (en) * 2006-08-15 2008-02-21 Anthrogenesis Corporation Umbilical cord biomaterial for medical use
US8372437B2 (en) * 2006-08-17 2013-02-12 Mimedx Group, Inc. Placental tissue grafts
CA2736663C (en) * 2007-09-07 2018-01-02 Surgical Biologics, Llc. Placental tissue grafts and improved methods of preparing and using the same
KR100947553B1 (ko) * 2008-02-14 2010-03-12 주식회사 바이오랜드 생체조직 이식재 및 그의 제조 방법
US9480549B2 (en) 2008-04-25 2016-11-01 Allosource Multi-layer tissue patches
WO2011031489A2 (en) * 2009-08-25 2011-03-17 Tissuetech, Inc. Umbilical cord amniotic membrane products
WO2012003377A2 (en) * 2010-06-30 2012-01-05 Tissuetech, Inc. Methods of preparing chorion tissue and products derived therefrom
KR20210104178A (ko) * 2011-02-14 2021-08-24 미메딕스 그룹 인크. 바르톤 젤리로 이루어진 라미네이트된 조직 이식편 및 그것의 제조 및 사용 방법
CN103874762A (zh) * 2011-08-26 2014-06-18 组织技术公司 胎儿支持组织的灭菌方法
ES2695579T3 (es) * 2011-12-30 2019-01-09 Vivex Biomedical Inc Matriz de regeneración de tejido
CN105521523A (zh) 2015-11-20 2016-04-27 金艺鹏 一种犬羊膜的制备及保存方法
TW201733600A (zh) 2016-01-29 2017-10-01 帝聖工業公司 胎兒扶持組織物及使用方法
NZ753034A (en) * 2016-11-02 2023-04-28 Axogen Corp Amnion tissue grafts and methods of preparing and using same

Also Published As

Publication number Publication date
NZ753034A (en) 2023-04-28
JP7482958B2 (ja) 2024-05-14
CL2019001212A1 (es) 2019-09-23
IL301474B2 (en) 2025-09-01
JP7171588B2 (ja) 2022-11-15
AU2017353847B2 (en) 2022-04-21
KR20230031381A (ko) 2023-03-07
JP2019536596A (ja) 2019-12-19
US11577001B2 (en) 2023-02-14
IL301474A (en) 2023-05-01
AU2017353847A1 (en) 2019-05-23
IL266381B1 (en) 2023-12-01
EP3534981A2 (en) 2019-09-11
US20190282732A1 (en) 2019-09-19
NZ793788A (en) 2024-10-25
MX2019005172A (es) 2019-09-26
US20230191001A1 (en) 2023-06-22
CA3042751A1 (en) 2018-05-11
WO2018085527A3 (en) 2018-06-28
JP2022184888A (ja) 2022-12-13
US12263276B2 (en) 2025-04-01
EP3534981B1 (en) 2025-12-24
AU2022206749A1 (en) 2022-08-18
IL301474B1 (en) 2025-05-01
EP4663211A2 (en) 2025-12-17
IL266381B2 (en) 2024-04-01
KR102514753B1 (ko) 2023-03-27
SG11201903899VA (en) 2019-05-30
MX2023007919A (es) 2023-07-13
AU2022206749B2 (en) 2024-05-30
IL266381A (en) 2019-06-30
EP3534981A4 (en) 2020-06-24
KR20190104991A (ko) 2019-09-11
KR102860731B1 (ko) 2025-09-15
WO2018085527A2 (en) 2018-05-11
KR20240110869A (ko) 2024-07-16

Similar Documents

Publication Publication Date Title
MX2020012797A (es) Anticuerpos biespecificos anti-pvrig/anti-tigit y métodos de uso.
MX2019007021A (es) Anticuerpos il-11ra.
MX2019007020A (es) Anticuerpos il-11.
IL278016A (en) A method to improve the suppressive properties of TREG cells
EP4465050A3 (en) Anti-tau antibodies and methods of use
PH12017500861A1 (en) Anti-interleukin-33 antibodies and uses thereof
EP4280554A3 (en) Method for transmitting he-ltf sequence and apparatus
NZ731467A (en) Anti-tim3 antibodies and methods of use
PH12022550646A1 (en) Anti-klk7 antibodies, anti-klk5 antibodies, multispecific anti-klk5/klk7 antibodies, and methods of use
CR20230163A (es) ANTICUERPOS ANTITAU Y MÉTODOS DE USO (Divisional 2019-0271)
MX2017001981A (es) Inhibidores de diana de rapamicina en celulas de mamifero de complejo 1 (mtorc1).
MX2021003180A (es) Métodos y kits para preparar sangre entera con inactivación de patógenos.
WO2014072982A3 (en) Tools and systems for solid form and graft implantation
EP3687546A4 (en) COMPOSITIONS AND METHODS FOR TREATING HEART DISEASE WITH REDIRECTED T-LYMPHOCYTE IMMUNOTHERAPIES
PH12020551292A1 (en) Moscato wine replicas produced from individual components
IL251616B (en) Methods and compounds for the treatment and prevention of muscle mass loss
AU2015205476A1 (en) Method for manufacturing osteosynthesis devices, osteosynthesis devices and implants made of semi-synthetic hybrid material obtained by structural modification of the components of a natural marine biomaterial
EP3646745A4 (en) HAIR PIECE, METHOD FOR MANUFACTURING A HAIR PIECE AND METHOD FOR TREATING A HAIR PIECE
MY181061A (en) Methods and apparatus for making molded objects, and molded objects made therefrom
JOP20190164B1 (ar) تركيبات وطرق لعلاج داء فاربر
MX2024008143A (es) Injertos de tejido amniotico y metodos para preparar y usar los mismos.
MX2017009180A (es) Biomateriales de nanocelulosa sintetizada bacterialmente y de fases múltiples, y método para producirlos.
AU2018279738A1 (en) Methods of enhancing development of renal organoids and methods of using the same
PH12021553111A1 (en) Sake replicas produced from individual components
MX2019014475A (es) Formulaciones de lixivaptan para el tratamiento de enfermedades poliquisticas.